Answers are grounded in this paper and cite their sources.
The role of obesity in human papillomavirus (HPV) persistence and the development of cervical neoplasia remains incompletely understood. This study evaluates the independent effects of obesity, smoking, and age on high-risk HPV persistence and the development of high-grade cervical lesions (cervical intraepithelial neoplasia [CIN]2+), and assesses whether obesity improves prediction of CIN2+. This retrospective cohort study included 445 women who underwent high-risk HPV testing between December 2023 and December 2025. HPV persistence was defined as detection of the same HPV genotype in at least two consecutive tests performed ≥ 12 months apart. Body mass index was categorized as non-obese (<30 kg/m2) or obese (≥30 kg/m2). Multivariable logistic regression analyses were performed to identify independent determinants of HPV persistence and CIN2+. Receiver operating characteristic curve analysis was used to compare a baseline model including age and smoking with an extended model additionally including obesity. Persistent HPV infection was identified in 59 women (13.3%). Smoking was a strong independent predictor of HPV persistence (adjusted odds ratio [aOR]: 13.07; 95% confidence interval [CI]: 6.54–26.09; p < 0.001), and increasing age was also independently associated with persistence (aOR: 1.04 per year; 95% CI: 1.01–1.07; p = 0.023). Obesity was not independently associated with HPV persistence. CIN2+ was detected in 95 women (21.3%). Obesity was independently associated with CIN2+ (aOR: 1.96; 95% CI: 1.14–3.38; p = 0.015), whereas smoking and age were not significant predictors. The addition of obesity modestly improved discrimination for CIN2+ prediction (area under the curve [AUC] 0.545 vs. 0.587). Smoking and age are key determinants of HPV persistence, whereas obesity appears to be associated primarily with cervical neoplastic progression rather than viral persistence. The modest increase in AUC suggests limited but measurable predictive contribution of obesity to CIN2+ risk.
No takes yet. Share an insight, caveat, or question.
Özdemir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: